Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420621 · ClinicalTrials.gov registry record · NA
Preliminary Effectiveness of Enhanced Text Message + Incentives
A NA study of Pregnancy and Smoking Cessation, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07420621: Recruiting NA study of Pregnancy and Smoking Cessation, sponsored by University of Kansas Medical Center.
NCT07420621 is a NA study of Pregnancy and Smoking Cessation that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 30 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420621, a NA study of Pregnancy and Smoking Cessation, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a preliminary evaluation of a smoking cessation intervention designed for pregnant women that combines text message support and financial incentives. The aims of this study are to determine the preliminary feasibility and acceptability of text message + incentives (intervention) vs. text message only (control).
Primary Outcome
Retention rate.
Conditions Studied
Interventions
- BEHAVIORAL Text Messages
- BEHAVIORAL Incentives
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-02-20 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
What NCT07420621 shows while recruiting
NCT07420621 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Text Messages is the first listed.
NCT07420621 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT07420621 about?
NCT07420621 is a clinical study titled "Preliminary Effectiveness of Enhanced Text Message + Incentives". This study is a preliminary evaluation of a smoking cessation intervention designed for pregnant women that combines text message support and financial incentives. The aims of this study are to determine the preliminary feasibility and acceptability of text message + incentives (intervention) vs. t...
What is the current status of trial NCT07420621?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-20. Estimated completion is 2026-08-01.
What conditions does trial NCT07420621 study?
This clinical trial studies the following conditions: Pregnancy, Smoking Cessation.
What interventions are being tested in trial NCT07420621?
The interventions under investigation include: Text Messages (BEHAVIORAL), Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT07420621?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420621 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07420621's enrollment target sits among peer trials
30 170th of 191 higher than 19 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI